Your browser doesn't support javascript.
loading
Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy.
Gu, Hongfeng; Yan, Wenxin; Yang, Jieping; Liu, Beibei; Zhao, Xiaolin; Wang, Hongxia; Xu, Wenbo; Wang, Chenghao; Chen, Yang; Dong, Qiuyi; Zhu, Qihua; Xu, Yungen; Zou, Yi.
Affiliation
  • Gu H; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
  • Yan W; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Yang J; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Liu B; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Zhao X; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Wang H; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Xu W; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Wang C; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Chen Y; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Dong Q; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Zhu Q; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Xu Y; Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211198, China.
  • Zou Y; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
J Med Chem ; 67(3): 1932-1948, 2024 Feb 08.
Article in En | MEDLINE | ID: mdl-38059836
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poly(ADP-ribose) Polymerase Inhibitors / Immunotherapy / Neoplasms Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2024 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poly(ADP-ribose) Polymerase Inhibitors / Immunotherapy / Neoplasms Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2024 Document type: Article Affiliation country: China Country of publication: United States